doses

Additional doses of SARS-CoV-2 increase the antibody response in patients with IBD

Source / Publication Published: Source: Quan J, et al. Poster 654. Presented at: Digestive Disease Week; 21-24 May 2022; San Diego (hybrid meeting). Disclosure: Quan has no relevant financial information. ADD TOPIC TO E-MAIL NOTIFICATIONS Receive email when new articles are published Please enter your e-mail address to which you will be sent an e-mail …

Additional doses of SARS-CoV-2 increase the antibody response in patients with IBD Read More »

Future booster doses of COVID-19 are likely to require new formulations as new coronavirus variants are still emerging that raise concerns.

Future booster doses of COVID-19 are likely to require new formulations as new coronavirus variants are still emerging that raise concerns.

Having up-to-date information on COVID-19 vaccines means having three or four doses of the same dose at this time. The current boosters are the same formulations as the first permitted injections based on the original coronavirus strain, which appeared in late 2019. It still protects against serious COVID-19 disease, hospitalizations and deaths. But as immunity …

Future booster doses of COVID-19 are likely to require new formulations as new coronavirus variants are still emerging that raise concerns. Read More »